Us Rabies Monoclonal Antibody Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
Rabies Monoclonal Antibody Market was valued at USD 0.12 Billion in 2022 and is projected to reach USD 0.18 Billion by 2030, growing at a CAGR of 5.4% from 2024 to 2030.
The US rabies monoclonal antibody market is witnessing significant growth as a result of rising concerns over the spread of rabies and the growing awareness of advanced medical treatments. Rabies, though rare in the United States, remains a deadly disease with high mortality rates once symptoms appear. As such, the introduction of monoclonal antibodies (mAbs) has offered a novel approach to managing exposure and preventing the onset of rabies after an animal bite.
Monoclonal antibodies for rabies treatment work by neutralizing the rabies virus, providing passive immunity until the body can mount its own immune response. The US market has seen considerable investment in research and development as pharmaceutical companies look to improve efficacy, safety, and availability of rabies mAbs.
The current landscape is shaped by a few key players in the biotechnology sector, with major companies racing to develop and commercialize rabies mAbs. One prominent example is the approval of monoclonal antibody therapies like Rabavert and others that target the rabies virus specifically. These therapies are often used in combination with the rabies vaccine to ensure comprehensive protection.
In 2025, the market is expected to grow further due to an increase in dog bite incidents, animal rabies cases, and the push for rapid treatment solutions in emergency settings. The increasing adoption of monoclonal antibodies will also be fueled by the growing healthcare infrastructure in the US, alongside better awareness programs aimed at preventing rabies transmission.
Notably, the market share for monoclonal antibody therapies is expanding within the global healthcare environment, where treatments are reaching underserved areas. In particular, regions with high animal rabies prevalence stand to benefit from improved access to treatment options like rabies mAbs. As the demand for effective post-exposure treatments grows, more attention is being placed on ensuring faster delivery systems, such as through 100 Gigabit Fiber Optic Transceiver Market applications in medical infrastructures to aid in quicker diagnostics and treatments.
As we look toward the future of rabies treatment in the US, the role of monoclonal antibodies seems increasingly vital. Their integration into clinical protocols, supported by advancements in technology and research, could make rabies a much less formidable threat in the coming years.
Get an In-Depth Research Analysis of the Global Rabies Monoclonal Antibody Market Size And Forecast [2025-2032]
Serum Institute of India
NCPC
Crucell
Zydus
Synermore Biologics
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Rabies Monoclonal Antibody Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Rabies Monoclonal Antibody Market
Human Rabies Immune Globulin (HRIG)
Monoclonal Antibodies
Recombinant Vaccines
Cocktail Antibodies
Intramuscular Injection
Intravenous Injection
Subcutaneous Injection
Intradermal Injection
Post-Exposure Prophylaxis (PEP)
Pre-Exposure Prophylaxis (PrEP)
Clinical Treatments
Research and Development
Hospitals
Clinics
Research Institutions
Pharmaceutical Companies
Direct Sales
Online Pharmacies
Pharmaceutical Distributors
Retail Pharmacies
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Rabies Monoclonal Antibody Market Research Analysis
1. Introduction of the Global Rabies Monoclonal Antibody Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Rabies Monoclonal Antibody Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Rabies Monoclonal Antibody Market, By Type
6. Global Rabies Monoclonal Antibody Market, By Application
7. Global Rabies Monoclonal Antibody Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Rabies Monoclonal Antibody Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/